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Diabetes is one of the most serious public health problems of the twenty first century 
(Albright, 2007; Glasgow et al., 1999). The rate of increase in the occurrence of diabetes and its 
complications has placed a tremendous burden on the American health care system and threatens 
to affect close to one third of the population in the next thirty years.  Diabetes complications 
markedly reduce the quality and length of life and contribute to enormous health care costs. 
Several large studies have shown that effective treatments and practices may substantially reduce 
the impact of diabetes (Herman, 2007). 
Performance measures for diabetes have been in place since the late 1990s (Murphy, 
Chapel, & Clary, 2004). There is evidence that control of outcome measures such as LDL-
cholesterol, blood pressure and HgbA1c have a positive impact on reducing the severity and 
progression of diabetes. The systems change project was developed to pilot a facilitator model 
for system change using evidence based quality measures to improve diabetes outcomes in a 
small primary care clinic. Results of the project showed significant improvement in the effects of 
clinicians (random effects) on diabetes outcome measures (fixed effects) for LDL-cholesterol (p 
= 0.017), HgbA1c (p = 0.004), and tobacco nonuse (p = 0.0051). The change in percent 
composite outcome measures for diabetes was also significant (p = 0.01). The hierarchical 
generalized linear model was used to account for provider impact on patient outcomes. Response 
to the facilitator model was generally positive as a means of promoting a quality improvement 
initiative in diabetes, encouraging a multidisciplinary model of chronic disease management and 
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The Effect of Practice Facilitation on Diabetes Registry Outcome Measures 
Chapter 1 
Background 
Diabetes is a major public health problem with tremendous medical, economic, and 
personal consequences.  It is a chronic illness that affects people across the lifespan, and is one 
of the most costly diseases to the United States (Glasgow et al., 1999; Narayan, Boyle, 
Thompson, Sorenson, and Williamson, 2007). If not diagnosed and treated properly diabetes can 
lead to serious complications such as heart disease, stroke, blindness, lower-limb amputations, 
kidney failure, disability and premature death. 
Rising Prevalence 
Diabetes is a chronic and devastating disease that now affects 8.3% of the United States 
(U.S.) population, and 11.3% of Americans over the age of twenty (American Diabetes 
Association, 2011).  Diabetes is the seventh leading cause of death in the U.S. (Centers for 
Disease Control and Prevention, 2012). The number of new cases of diabetes diagnosed each 
year began to increase in 1992. From 1990 to 2010 the incidence of diabetes in the US nearly 
tripled. The prevalence of diabetes in the United States also remained constant until the early 
1990s. Between 1990 and 2010, the prevalence of diabetes nearly quadrupled (Centers for 
Disease Control and Prevention, 2012). If current trends continue, the Centers for Disease 
Control and Prevention projects that by 2050, one in three adults in the US will have diabetes, an 
increase of more than 163% (Boyle, Thompson, Gregg, Barker, & Williamson, 2010; Centers for 
Disease Control and Prevention, 2012). 
The development of diabetes is strongly linked with aging, obesity, and the increasing 




2012). Sixteen percent of people over the age of 65 have diabetes as opposed to 2% of people 
age 20 to 45 (Centers for Disease Control and Prevention, 2012).  The prevalence of diabetes is 
also higher among certain racial and ethnic groups such as Hispanics and Blacks, but is 
increasing most rapidly among Native Americans (Agency for Healthcare Research and Quality, 
2008). 
Complications of Diabetes  
 Diabetes is now the seventh leading cause of death in the United States (Centers for 
Disease Control and Prevention, 2012). People with diabetes are at great risk for serious and life-
threatening complications. Adults with diabetes have a two to four fold greater chance of 
developing heart disease or having a stroke (National Diabetes Information Clearinghouse, 
2012). Small blood vessel changes in diabetes lead to an increased risk of eye, kidney and nerve 
disease. Diabetes is the leading cause of adult kidney failure and a major contributor to adult 
blindness (Centers for Disease Control and Prevention, 2012).   The combination of circulatory 
and nerve disease leads to an increased occurrence of lower-limb amputations (American 
Diabetes Association, 2011). People with diabetes can, over time, develop nerve damage 
throughout their body which can lead to chronic pain, immobility, and long-term disability 
(National Committee for Quality Assurance, 2012). The long prodromal phase before diabetes is 
diagnosed results in a high rate of complications that are already present at the time the diagnosis 
is made (Deshpande, Harris-Hayes, & Schootman, 2008). 
Poorly controlled diabetes before conception and during pregnancy can cause major birth 
defects, spontaneous abortions, and excessively large babies posing a risk to mother and child 




has been associated with an increased risk of metabolic syndrome and diabetes in the offspring 
(Boney, Verma, Tucker, & Vohr, 2005).   
The High Cost of Diabetes 
 The costs associated with diabetes are staggering. The average medical expenditures  
among people with diagnosed diabetes are 2.3 times higher than for people without diabetes 
(American Diabetes Association, 2011). Data released by the Centers for Disease Control in 
2007 show that the total cost of diagnosed diabetes in the United States was $174 billion. This 
amount included $116 billion of direct medical costs and $58 billion of indirect costs from 
disability, work loss and premature death (Centers for Disease Control and Prevention, 2011; 
Gilmer et al., 2005). A sampling of 10 million commercial health plan members, showed that the 
average annual costs incurred by a patient with diabetes in 2009 was $11,700 compared with the 
annual costs of $440 for a patient without diabetes. The average annual cost incurred by a 
diabetic patient with complications was $20,700, nearly three times that of a diabetic patient 
without complications (United Health Center for Health Reform & Modernization, 2010).  
 The current approach to diabetes care is projected to see annual costs (in 2012 dollars) 
rise from $156 billion in 2010 to $192 billion by 2020 with direct medical costs increasing to 
$138 billion and indirect costs from lost productivity increasing to $54 billion (U.S. Department 
of Health and Human Services, 2004; Winterfeld, 2009). By some estimates, there is a real 
possibility that diabetes will bankrupt the healthcare system (American Association of Clinical 
Endocrinologists, 2011). 
Disparities in Health Care 
 The greatest burden of diabetes falls on racial and ethnic minorities (Prina, 2010; Sequist 




of persons with diabetes and the characteristics of their communities or neighborhoods may 
determine their risk of mortality and diabetes-related complications (Brown et al., 2004; White et 
al. 2009). The National Health Interview Surveys documented lower educational attainment, 
higher unemployment, and lower family income among Americans who reported having diabetes 
(Mann, Ponieman, Leventhal, & Halm, 2009; Sequist et al., 2008). A study conducted by White 
et al. (2009) found that more than half of low-income minorities with diabetes held major 
misconceptions about diabetes and its management that significantly and negatively impacted 
disease treatment outcomes. 
Among Hispanics, the fastest growing minority population in the U.S., the prevalence of 
diabetes is two times that of non-Hispanic Whites (Braverman, Cubbin, Egerter, Williams & 
Pamuk, 2010; Centers for Disease Control and Prevention, 2001) and increases significantly for 
those with less than a high school education (Brown et al., 2011). The lifetime risk for 
developing diabetes is greater among Hispanics than any other ethnic groups (Centers for 
Disease Control and Complications, 2011). Between 1990 and 1998 the number of American 
Indians and Alaska Natives with diabetes increased 71% (Agency for Healthcare Research and 
Quality, 2008). Rates of diabetes related deaths is higher among Blacks, American Indians, and 
Hispanics than for Whites (Centers for Disease Control and Prevention, 2012), and diabetes is 
the fifth leading cause of death for Asian and Pacific Islanders (National Diabetes Information 
Clearinghouse, 2012).  
Certain minority groups also have much higher rates of diabetes related complications, in 
some cases as much as 50% more than the diabetes population as a whole (Hale et al., 2010). 




stage renal disease and lower extremity amputations (Agency for Healthcare Research and 
Quality, 2001; White et al., 2009). 
Effectiveness of Interventions 
Diabetes has a tremendous impact on health spending and quality of life for those 
affected by the disease. Yet type 2 diabetes, the most common form, can be prevented and 
controlled. Research findings indicate that diabetes prevention and management works (Albright, 
2010; Hale et al., 2010; Nguyen, Nguyen, & Felicetta, 2008). The Diabetes Prevention Program 
showed a 58% reduction in the onset of diabetes over a three year period through the use of diet 
and exercise alone (National Diabetes Information Clearing House, 2011). Studies in China and 
Finland have had similar results (Pan et al., 1997; Tuomilehto et al., 2001). Findings from The 
Diabetes Control and Complications Trial; The United Kingdom Prospective Diabetes Study 
Group; and the Action to Control Cardiovascular Risk in Diabetes Trial show that with the 
proper treatment and glucose control, complications can be minimized (National Institutes of 
Health, 1993; National Institutes of Health, 2008; Turner, Cull, & Holman, 1996). State diabetes 
prevention and control programs, funded partially by the Centers for Disease Control and 
Prevention, have been associated with noticeable improvements in diabetes prevention and 
treatment (Centers for Disease Control and Prevention, 2011). Successful prevention and 
management of diabetes can decrease the high cost of care and improve the quality of life for all 
people affected by the disease. 
Return on Investment 
  Public health experts agree that investing in diabetes prevention and control efforts can 
improve health outcomes across populations and reduce health care costs nationally (Agency for 




Complication and Control Trial showed that even at two to three times the expense of 
conventional therapy, the lifetime costs of improved care were offset by the lifetime costs of end-
stage renal disease, blindness and lower-limb amputations (Diabetes Control And Complications 
Trial, 1996; Herman & Eastman, 1998). Sidorov et al. (2002) determined that comprehensive 
care for diabetes in a managed care program resulted in per month claims of $394.62 for 
enrollees in the program versus per month claims of $502.48 for those with diabetes not enrolled 
in the program. Beaulieu et al. (2006) estimated the cumulative discount in net savings to the 
health plan for patients enrolled in a diabetes program for 10 years was $5,345 per diabetic 
member. Nuckols et al. (2011) found that the cost of care for improved diabetes control was 
$830.39 annually as opposed to $503.38 annually for those with status quo care, but calculated 
the cost effectiveness ratio to be $44,869/quality adjusted life year (U.S. dollars for 2009) for 
those with good diabetes control as defined by HgbA1C <8%. 
A growing body of research indicates that payers, patients, and society in general can see 
a long-term return on investment in diabetes quality improvement (Klonoff & Schwartz, 2008; 
Krause, 2005). Cost savings are difficult to calculate accurately because of the large number of 
individuals who have diabetes and have yet to be diagnosed, and those who have diabetes but 
have not sought treatment. Additionally, evidence points to the fact that the real cost savings for 
diabetes occur far in the future, and are even more difficult to accurately quantify. Research 
shows that improved care makes a significant difference on all levels. 
Healthcare Mandate 
The American health care system has difficulty routinely and consistently translating 
research into practice, adhering to guidelines for proper care, and improving health care 




estimated that 50% of people with diabetes are as yet, undiagnosed (International Diabetes 
Federation, 2010). Others who are diagnosed lack adequate treatment and do not know how to 
manage their disease well over time (Agency for Healthcare Quality Improvement, 2008). 
A 2006 survey of diabetes care based on data from the National Health and Nutrition 
Examination Survey and the Behavioral Risk Factor Surveillance System found that only 42% of 
individuals with diabetes had glycosylated hemoglobin (HgbA1c) levels less than 7% (optimal 
control), a number that has not substantially changed since 1998 (Agency for Healthcare Quality 
Improvement, 2008). In Minnesota the statewide rate for optimal diabetes control at the clinic 
level in 2010 was 37% (Minnesota Community Measurement, 2011).  
Legal and Political Mandate 
The U.S. government has in the last several years, taken a more active role in a range of 
programs and initiatives to decrease the impact of diabetes. There is an imperative to extend that 
engagement to all levels of the health system and all sectors of government and the public to 
address determinants of disease and transform the system from one of sickness to one of health 
promotion (O'Connor, 2012; Kahn, 2009). In 2007, the National Council on Development 
Planning commissioned Mathematica Policy Research, Inc. (Novo Nordisk, 2012) to identify the 
range and kinds of federal programs, authority, and funding that would influence the incidence, 
prevalence, treatment, and progression of diabetes. The results show there was a lack of 
effective, coordinated federal leadership and spending in diabetes prevention, treatment, and 
care. Yauch, Hawkes, Linn, Gould, and Galbraith (2004) identified three strategies for change: 1) 
raising the profile of chronic disease in the minds and on the agenda of policy makers; 2) 
providing policy makers with the necessary evidence to support the case for prevention; and 3) 




Determinants of Health and Social Justice 
In the U.S. today, the single largest cause of poor health outcomes is chronic disease 
(Centers for Disease Control and Prevention, 2012). Evidence now indicates that the most 
powerful predictor of whether a person will develop a chronic disease is their socioeconomic 
status (Bell et al., 2010; Braverman et al.; Sequist et al., 2008; White et al., 2009). The 
socioeconomic factor is because higher income increases the probability that people can and will 
choose healthier food and activity levels. Research shows that individuals with higher incomes  
suffer less from chronic stress which interacts with the immune and neurological system to set up 
risk factors for many chronic diseases.  
Larger social systems that support and surround the individual are influenced by and in 
turn influence, the individual both positively and negatively. Management of diabetes occurs 
largely in outpatient settings and most often in primary care clinics. Sequist et al. (2008) found 
that patient sociodemographic factors explained 13% to 38% of the racial differences in 
improving diabetes outcome measures. Unfavorable social conditions and ineffective self-
management often have a greater impact on health outcomes than planned interventions from 
medical providers. In such a context, the most important determinants of health are the patients 
and their interactions with the environment around them. It is essential to look beyond the care of 
the individual patient to the health of the larger community with attention to equity and the most 
efficient use of resources in ways that enhance patient and community quality of life. 
Quality improvement in diabetes is really about equity in health care delivery. Health 
disparities produce avoidable suffering, diminish human resources, and decrease productivity on 




to the equal treatment for individuals or groups with the same or similar levels of health care 
need (Ward, 2009). Horizontal equity is an essential component of quality chronic disease care. 
The doctor of nursing practice curriculum and the system change project is rooted in the 
imperative to seek out inequities within the system, and create a vehicle for change that can be 
self-sustaining and transformative. Such an opportunity occurs with this diabetes project. As a 
result of the intervention, providers express greater confidence, satisfaction, and success in their 
ability to care for their diabetes patients, build productive relationships with their patients, and 
provider teams, and meet organizational expectations. Patients generally are able to see 
improvement in their diabetes outcomes and consequently have the opportunity to decrease 
complications and improve their quality of life. Most importantly, care is distributed equally 
without regard to the individual’s race or ethnicity. There are three domains of equity within 
healthcare: equal access to health care for people in equal need; equal treatment for people in 
equal need; and equal outcomes for people in equal need (Ward, 2009). Issues of access are only 
marginally addressed by process and outcome measures for quality improvement. Improvement 
in quality of care more directly applies to treatment, and outcomes.  
The diabetes management regime is among the most demanding regimes of any chronic 
illness and is based on a number of lifestyle changes that people with diabetes often find difficult 
to incorporate into their everyday lives. Improving care delivery is essential to developing a 
more supportive and optimal environment for long term chronic disease management (Averbeck 








According to Baskerville, Liddy, & Hogg (2012), practice facilitation is a multifaceted 
approach that involves skilled individuals who enable others through a range of intervention 
components and approaches to address the challenges in implementing evidence-based care 
guidelines within the primary care setting.  Facilitators are individuals with recognized skills in 
an identified area of health care and who are perceived as credible implementers of change. The 
role does not impose ways of working on individuals, is neither prescriptive nor directive, but 
strives to help people recognize and attain their greatest potential. Facilitation has been 
increasingly used in Europe and Canada since the early 1980s, but is a relatively new concept in 
the U.S. 
The facilitation process itself is by nature both fluid and organized in that clear practice 
guidelines are the basis for the needed change, but introduction and adaptation to the individual 
and the context are essential to the successful incorporation of the new methods of operation. As 
such, a diversity of approaches in moving evidence into practice reflects the multifaceted nature 
of facilitation. Important roles for the facilitator are to promote awareness for the need for 
change, provide leadership and management of the change process, encourage relationship 
building and communication, and provide ongoing mentoring, monitoring, and evaluation. 
Several elements of the facilitation process were attractive for the systems change 
project. Essential components of facilitation were the process of individual and group interaction 
that was the basis for improved understanding, problem solving, and incorporation of new 
patterns into daily clinic practice. The opportunity to tailor the facilitation to the local context 
and to provide individual support and encouragement through the change process offered a 





 Health care organizations and individual healthcare providers have been under increased 
pressure to improve treatment outcomes, especially in the area of chronic disease management. 
The Diabetes Quality Improvement Project founded in 1997 through a partnership between the 
Center for Medicare and Medicaid Services, the National Committee for Quality Assurance, and 
the American Diabetes Association, established a single, standardized set of performance 
measures for diabetes care quality improvement and accountability in the U.S. Changes in the 
healthcare system to promote improved outcomes were given impetus by the Institute of 
Medicine report in 2001 that called for providing physicians with more financial incentives for 
quality improvement (Institute of Medicine, 2001). Further changes thorough the Affordable 
Care Act of 2010 at the national and state level have increased the surveillance for diabetes and 
strengthened the mandate for healthcare organizations to adopt comprehensive programs to 
improve outcome measures. The development of diabetes registries that track outcomes for 
patients with diabetes have been an important part of this process. The result of these activities is 
that local healthcare organizations are strongly encouraged to follow federal guidelines to ensure 
compliance, reimbursement and better patient outcomes. 
 This project took place in a multispecialty primary care clinic that is part of a large 
organization located in the Midwest, U.S. The larger organization is a non-profit institution that 
primarily serves an urban population. The mission and vision of the larger organization are to 
serve the community by providing exceptional care, preventing illness, restoring health, and 
providing comfort to all members. The organization’s vision is to put the patient first and lead 




 In 2009, a small, multidisciplinary practice comprised of eight medical clinics and four 
urgent care centers in the Twin City area was absorbed into the much larger healthcare 
organization that was composed of over one hundred clinics and urgent care centers and ten 
hospitals throughout the state of Minnesota. The larger system was a recipient of the American 
Medical Group Foundation’s 2008 Acclaim Award for its initiative around optimal diabetes care 
(Sanderson-Austin, Branning, Bauwens, & Smith, 2009). It also was a two-time recipient of the 
Minnesota Bridges to Excellence Award (2008 & 2011) for exceptional diabetes care. A stated 
goal of the larger healthcare organization was to extend the diabetes care initiative activities to 
include the newly acquired practice. 
Organizational Structure 
 Within the context of these national and organizational mandates, one small healthcare 
system became the focus of a systems change project to facilitate improved diabetes 
management outcomes. This clinic is part of the smaller system that was absorbed into the much 
larger organization. Practice context differed greatly between the smaller system and larger 
organization. The small, primary care clinic consists of nine internal medicine and family 
practice physicians, two primary care nurse practitioners, and eleven clinical assistants. The first 
language of four of the physicians is not English and they received their medical training outside 
the United States. The clinic is located in the second largest county in the state and serves a 
largely suburban population. The county is in the lowest one third of the state’s health status 
morbidity and mortality rankings and lowest one third of the state’s social and economic factors 
rankings (Robert Woods Johnson & University of Wisconsin, 2011). Two thirds of the county 
population is white with the remaining one third consisting primarily of Black and Asian 




16% of the population has an income that is below the poverty level (GeoLytics, 2011). The 
prevalence of diabetes in this county in 2009 was 7.2% (Centers for Disease Control and 
Prevention, 2011). The number of patients with diabetes on each physician’s registry ranged 
from 16-106 with four of the six physicians having more than 50 patients on their registry.   
Providers’ Expectations 
 Patients with diabetes in the smaller system were added to the organization-wide diabetes 
registry and all providers in the smaller system were given year-end diabetes outcome targets to 
achieve for their panel of patients. Outcome targets were based on Minnesota Community 
Measures evidence-based guidelines with a year-end goal of 38% percent achievement 
established by the parent organization.   
 This initiative produced considerable confusion on the part of providers in the smaller 
system as there was limited communication about the rationale for the initiative and the choice of 
outcome measures utilized. Additionally, there was no organized diabetes program in the smaller 
system, nor was there a program in place to educate and support the physicians who sought to 
improve diabetes outcomes for their patients. There was also a clear understanding 
communicated to all physicians that financial remuneration, and perhaps job security, was 
connected to success in meeting outcome goals. 
Problem Statement  
Monthly diabetes outcome reports and adherence to recognized standards or outcome 
measures have been linked to job performance reviews and incentive pay for providers. 
Individual providers have been under increased pressure to change practice patterns to achieve 
outcome goals for all their patients. Demands of a busy practice, limited reimbursement for 




treatment options make it extremely difficult for the primary care provider to deliver quality 
care. 
The systems change project was conceived out of the realization that providers in a small 
primary care clinic needed assistance to incorporate evidence based guidelines into their practice 
and gain confidence in caring for their patients with diabetes. At the same time, consumers 
needed to receive a level of care for their diabetes that met expected standards of care based on 
current evidence.  
Problem Purpose 
The purpose of the project was to deliver practice facilitation intervention to improve 
primary care providers’ comfort and improve diabetes quality of care within their primary care 
clinic. 
Research Question 
Does practice facilitation improve provider’s comfort with adult diabetes care delivery 
and improve diabetes outcome quality measures? 
Project Overview 
 Six primary care providers and their clinical assistants (provider teams) were coached on 
a one-to-one basis in the utilization of evidence based guidelines for the delivery of care to their 
patients with diabetes. A practice facilitation model incorporating a nurse practitioner diabetes 
specialist with volunteer participants was implemented for a period of four months.  The 
organizational diabetes registry was used to follow patients and adjust treatment. Diabetes 
outcome measures (LDL-cholesterol, blood pressure, glycosylated hemoglobin, tobacco nonuse 
and aspirin use) as well as composite measures of all five outcome measures were monitored 




organizational goals to have all providers improve the quality of diabetes care in their individual 
practices. 
Project Objectives 
 The objectives of this project were to evaluate the effectiveness of a practice facilitation 
coaching for providers and provider teams and to incorporate evidence-based guidelines into 
clinical practice for improved diabetes care. Outcome measures and monthly composite 
measures were used as indicators of improved care 
Project Aims 
1) To improve diabetes composite measures to a target of 38% by the completion of the 
project 
2) To increase providers’ knowledge and confidence in caring for their patients with 
diabetes. 
3) To improve health team processes for the delivery of evidenced based care to their 
patients with diabetes by more consistent use of diabetes registry data. 
Definition of Terms 
BP Blood pressure 
Composite measures Bundling of measures for a specific condition to determine 
if all critical aspects of care have been achieved 
HgbA1c Glycosylated hemoglobin, the average blood glucose level 
for the preceding three month period, expressed in a 
percent. 
LDL (cholesterol) Low density lipoprotein cholesterol, independent risk factor 
for heart disease 
Outcome measures Management goals for specific diseases that have been 
established by consensus as targets for quality care and 




Practice facilitator   Health professional who assists clinicians in research and 
quality improvement projects. 
Process measures Actions taken by a provider to improve the quality of care 
such as ordering tests, making referrals and performing 
examinations 
Provider Health care professional (physician, nurse practitioner, 
physician assistant or doctor of osteopathy) who directs and 
manages the health care for an individual patient 
Provider team A group of health professionals consisting of the provider, 
nurse and/or clinical assistant who work together to deliver 






The systems change project incorporates three theoretical frameworks: the  
science of unitary human beings theory by Martha E Rogers, the eight stage process for systems 
change by John Kotter, and the chronic care model developed  by Group Health’s MacColl 
Institute for Healthcare Innovation. Elements from each theory have direct application to the 
issues confronted by the project, and more particularly, to challenges inherent in working with 
individuals who are the providers and consumers of healthcare.  
Martha Rogers' Science of Unitary Human Beings  
Martha Rogers first published her theory in An Introduction to the Theoretical Basis of 
Nursing, (1970). Her work was in response to the need to establish nursing as a science and 
postulate a set of principles that would direct nurses’ thinking and activity (Butcher & Maliski, 
2010). Her work derived from extensive reading in the behavioral and physical sciences and her 
experience as a public health nurse and educator (Phillips, 2010).  Rogers’ theory has had a 
profound impact on nursing practice, research, and education as it articulated a model for nursing 
distinct from the traditional medical model, and more inclusive of an open-system world view 
(Butcher & Malinski, 2010; Wright, 2007).  Her science was rooted in a unitary consciousness 
paradigm that proposed energy fields as the fundamental unit of the living and nonliving 
(Watson & Smith, 2002; Wright, 2006). Humans are described as unitary and irreducible, and in 
harmonic interaction with the environment. As such, humans and the environment interact in a 
dynamic, infinite, and continuous manner.  Rogers’ postulates of energy fields, openness, and 
patterning (recognition through familiar patterns that are greater than the sum of their parts), 




irreversible space and time continuum yet without any spatial or temporal attributes (Klemm & 
Stashinko, 1997; Phillips, 2010; Watson & Smith, 2002). Rogers used the term homeodynamics 
to describe the dynamic, ever-changing nature of life and the world. She further identified three 
concepts associated with pattern manifestation. Resonancy was the term used to describe change 
that occurred in a nonlinear, continuous flow of higher and lower light frequency wave patterns. 
Heliacy described the creative, diverse nature of ongoing change, and integrality was the context 
in which change occurred, namely the mutual, inseparable human-environment field process 
(Phillips, 2010; Watson & Smith, 2002).  
The expanded world view in Rogers’ theory focuses attention on human life as a process 
of dynamic change that is unpredictable, creative, evolutionary, and continuous. Humans within 
this system are unique, whole, and greater than the sum of their parts, and in perpetual, reciprocal 
interaction with their environments. Rogers’ system is acausal since it has no boundaries and is 
in constant change (Barrett, 2010; Phillips, 2010). Humans and the environment interact 
continuously, creating new patterns, and participating in an irreducible wholeness.  Nursing’s 
goal then is to see these individuals within their environment, embrace the mutual process of 
interaction between the individual and the environment, and work to establish strategies and 
patterns that will promote health and well-being. Rogers’ model has application to all areas of 
health care practice and strongly influences response to change within a system. Change is 
continuous and must be accepted as a reality in all aspects of human interaction.  
Explicit assumptions in her model are focused on the unity of the individual, continuous 
reciprocal interaction with the environment, the dynamic evolution of existence, the capacity to 
influence patterns, and the worthiness of the process. Implicit in Rogers’ theory is the value and 




Effective engagement is predicated on the acceptance of unceasing change, and the uniqueness, 
and reciprocity between the individual and environment. 
Kotter's Eight Stage Process Model  
John Kotter, a Harvard Business School professor and graduate of Massachusetts Institute 
of Technology, has written extensively on change in organizations. His basic thesis, like Martha 
Rogers, is that change is constant. His model is based on research and direct observation of 
organizations around the world. He acknowledges a paradigm shift in organizations since the 
1960s from a focus on stability and predictability to one of continuous change and innovation 
(Kotter, 1996). He attributes the need for change to the major economic and social forces that 
have resulted in a globalization of both markets and competition. He identifies two important 
factors for successful change. The first is a multistep process that creates motivation and power 
which will counter the inertia within the organization. The second is the use of highly effective 
leadership that will establish direction, align people as change agents, and motivate and inspire 
people to overcome obstacles associated with the change process (Kotter, 1996). 
Kotter’s  eight-stage process (Table 1) is detailed and sequenced, with emphasis on the 
importance of completing each step before advancing to the next. The theory presents a view of 
the twenty-first century organization that is less bureaucratic than streamlined, externally 
oriented, and risk tolerant.  He advocates for a more open, candid, and empowering environment 
for employees. The theory maintains that successful transformation is largely the result of strong 
leadership and only marginally associated with good management (Kotter, 1996). He clearly 
defines what is meant by leadership, and argues convincingly that management is a less essential 






Kotter’s Eight Stage Process Model 
 









Form a powerful 
coalition 
 
Create a vision 
for change 
Develop a sense of urgency around the 
need that will spark the initial motivation 
Bring together a team of influential people 
with power from a variety of sources who 
will  support the change process 
Develop a brief summary of values behind 
the change and strategy for implementation 



























Talk about the vision openly, honestly, 
daily and apply to all aspects of the 
operation 
Develop and activate the structure for 
change and act to remove barriers to its 
development 
Create small, achievable targets that can 
motivate with results 
Build on what went right and identify how 
to improve by setting new goals 








The Chronic Care Model  
The chronic care model identifies the essential elements of a health care system that 
encourages high-quality chronic disease care. These elements are the community, the health 
system, self-management support, delivery system design, decision support, and clinical 
information systems. In combination, evidence-based change concepts under each element 
facilitate productive interactions between informed patients and providers with resources and 
expertise. Patients are at the center of the health care plan and take an active part in their care 
(Group Health's MacColl Institute for Healthcare Innovation, RAND, & California Health Care 
Safety Net Institute, 2008). One of the major problems addressed by the chronic care model is 
the fact that current care of chronic illness is often reactive and triggered by actual problems 
instead of being proactive, structured, and planned.  
Application to Systems Change Project 
Rogers’ theory directs attention to the essential role of each individual (both providers 
and consumers of health care) and the dynamic, complex, and reciprocal nature of interactions 
between individuals and their environments. Her theory supports principles of social justice and 
health equity by ensuring respect for all persons and imbedding change within the context of 
each individual’s life circumstance whether that be personal or professional. Kotter’s eight stages 
are a tool to formulate a plan for identifying the needed change, building support for the change, 
and moving from beginning to end of the change process.  His focus on leadership further 
supports the facilitator role. The chronic care model outlines specific components of ongoing 
chronic disease care that once again place the individual patient is at the center of the care 
process. The chronic care model incorporates the range of environments and organizational 




These theories and models support patient centered care and empower providers and consumers 
of health care to be collaborative in their efforts to improve the quality of their care. 
Literature Review 
Measuring Quality in Diabetes Care  
A great deal of progress has been made in the United States and Europe during the last 
fifteen years in the development, specification, and field-testing of measures for diabetes care 
(Nicolucci, Greenfield, & Mattke, 2006). Much of the work on standardized measures for quality 
care began in the U.S. with the formation of the Diabetes Quality Improvement Program which 
was a physician driven program (McLaughlin, 2000). The Diabetes Quality Improvement 
Program evolved into the National Diabetes Quality Improvement Alliance which is composed 
of national organizations that are concerned about the care of patients with diabetes (Agency for 
Healthcare Research and Quality, 2008).  
In clinical practice, two terms “standards of care” and “outcome measures”, are used 
frequently. It is important to note the distinction between these two terms. The standards of care 
for diabetes serve to provide health professionals, patients, researchers, payers, and other 
interested individuals with the components of diabetes care, treatment goals, and tools to 
evaluate quality of care (American Diabetes Association, 2012). Outcome measures are an 
indicator or tool used to assess the level of care provided within a system of care to populations 
of patients with diabetes (McLaughlin, 2000). Outcome measures do not reflect either the 
minimal or maximal level of care that should be provided. Measures do, however, serve as a 
consistent tool across health care systems to demonstrate the quality of care provided to its 
members. Outcome measures are evidence-based, derived from standards of care and positions 




diabetes care, research, education, data collection, medical reimbursement, and quality 
improvement (Agency for Healthcare Research and Quality, 2008).  
In 2007, the American College of Physicians published an article in which the Appraisal 
of Guidelines for Research & Evaluation (AGREE) instrument was applied to nine sets of 
diabetes practice guidelines (Qaseem et al., 2007). Of the nine guidelines, four (National Institute 
for Health and Clinical Excellence, Scottish Intercollegiate Guidelines Network, Veterans Health 
Administration and Canadian Diabetes Association) achieved the highest score. However, a 
review of the literature indicates that in addition to the National Institute for Health and Clinical 
Excellence guidelines, three other guidelines (American Association of Clinical 
Endocrinologists, American Diabetes Association, and Institute for Clinical Systems 
Improvement) now serve as a basis for the formulation of outcome measures in Minnesota 
(Minnesota Community Measures, 2008). It is important to note that the National Institute for 
Health and Clinical Excellence, the Institute for Clinical Systems Improvement, and as of 2012, 
the American Diabetes Association guidelines emphasize that glycemic control should be 
individualized for each patient. Glycemic control is especially important when tailoring 
treatment plans to individual patient’s health care needs and concerns, but become problematic 
when outcome measures do not accommodate such flexibility. 
Criteria for the development of quality performance outcome measures differ from 
clinical practice guidelines in that feasibility and variability are important considerations. 
Feasibility relates to whether the measure can be collected accurately, reliably, and at reasonable 
cost (Nicolucci et al., 2006). Variability relates to standardization of the measure across multiple 
health care settings (Nicolucci et al., 2006). All measures use the number of clinically diagnosed 




considered to have failed the standard. Missing data is similarly considered to be a failure. Great 
Britain, Canada, and the United States all have similar outcome measures that include A1c, and 
LDL-cholesterol levels (Klomp, Dyck, Cascagnette, & Teare, 2010; Si, Bailie, Wang, & 
Weeramanthri, 2010). Great Britain and Canada include annual screening for nephropathy and 
eye examination (Si et al., 2010). In the United States glycemic, lipid, and blood pressure control 
are the major areas of concern for most organizations (Ahmann, 2007, BioMed Central Health 
Services Research (2010).  
Types of Quality Measures  
Improving the quality of health care is dependent on the collection and analysis of data. 
The Agency for Healthcare Research and Quality defines data as “values or estimates generated 
to describe a concept and track it over time, space, and populations” (Agency for Healthcare 
Research and Quality, 2008, Module 2, p. 2). Data provides a means of identifying quality 
problems in healthcare, selecting possible solutions or interventions, evaluating the results of 
selected interventions, and tracking those results over time. Data can also be used to compare 
healthcare quality in different regions of the country or different health care systems within a 
region. The healthcare quality measures used at the national and state level for quality 
improvement relate to populations. The measures are often rates such as percentages that indicate 
the number achieving a goal relative to a population base. 
Most quality improvement efforts focus on process and outcome measures. Process 
measures are based on disease specific guidelines of care. Process measures are those actions 
taken by a healthcare provider to improve the quality of care such as the type of tests ordered, 




process measures are dependent on provider orders and actions they are often considered as 
performance indicators. 
The National Healthcare Quality Report process measures for diabetes are (Coffey, 
Matthews, & McDermott, 2008): 
• HgbA1c test-Percent of adults with diabetes who had a hemoglobin A1c 
measurement in the past year 
• Lipid profile-Percent of adults with diabetes who had a lipid profile in the past 2 
years 
• Eye exam-Percent of adults with diabetes who had a retinal exam in the past year 
• Foot exam-Percent of adults with diabetes who had a foot examination in the past 
year 
• Flu vaccination-Percent of adults with diabetes who received an influenza 
immunization in the past year 
Outcome measures refer to the patient’s health status or the results of specific treatment 
recommendations. They are considered to be a marker of how much the patient’s health has 
improved which is the ultimate objective of quality improvement efforts (Agency for Healthcare 
Research and Quality, 2008).  
The National Healthcare Quality Report outcome measures for diabetes are (Coffey et al., 
2008): 
Test results 
• HgbA1c levels-Percent of adults with diagnosed diabetes with HgbA1c levels 
>9.5% (poor control), <9.0% (needs improvement) and <7% (optimal control) 
• Cholesterol levels-percent of adults with diagnosed diabetes with most recent 
LDL-cholesterol level >130 mg/dl (needs improvement) or <100 mg/per dl  






Hospital admissions (per 1,000,000 population) 
• Hospital admissions for adults with uncomplicated, uncontrolled diabetes  
• Hospital admissions for adults with short-term complications of diabetes 
• Hospital admissions for adults with long-term complications of diabetes 
• Hospital admissions for lower extremity amputations for patients of all ages 
Process measures have been criticized for having limited connection to actual clinical 
outcomes (Nicolucci et al., 2006), and outcome measures have been criticized for not accounting 
for factors that are beyond the provider’s control such as patient preference, regime 
nonadherence, language barriers, etc. (Lovett & Liang, 2012). Composite measures are an 
attempt to improve on the low statistical significance of process and outcome measures by 
combining multiple measures in a single measurement (Lovett & Liang, 2012).  In this way, 
composite measures provide an overall summary of the quality of care delivered to a patient.  
The Institute of Medicine defines composite measures as “the bundling of measures for a specific 
condition to determine if all critical aspects of care… have been achieved for an individual 
patient, thereby enhancing measurement to extend beyond tracking performance on separate 
measures” (Institute of Medicine, 2006, p. 92). The American Medical Association supports the 
use of composite scores in addition to individual outcome and process measures as a more 
precise indicator of improvement that captures a spectrum of care (Physician Consortium for 
Performance Improvement, 2010). Use of a variety of measures encourages clinicians to focus 
on all aspects of care and facilitates more standardization for better interpretation of quality 
assessment efforts. Advantages of composite measures are that they are easier to interpret for 




achieving consensus on composite design and scoring and the loss of important information if 
the composite score combines unrelated metrics (Romano, Hussey, & Ritley, 2010). 
Measuring Quality of Diabetes Care from State and Federal Perspectives 
In the U.S., surveillance for diabetes care has changed focus from the use of Healthcare 
Effectiveness Data and Information Set (HEDIS) which includes measures for glycemic control, 
lipid control, blood pressure control, and medication for nephropathy (National Committee for 
Quality Assurance, 2011) to the Institute for Clinical Systems Improvement recommendations 
that glycemic control should be linked with cardiovascular risk reduction to include lipid and 
blood pressure control, aspirin use, and tobacco cessation. In 2010, the Institute for Clinical 
Systems Improvement guidelines were adjusted to target cardiovascular risk. Surveillance for 
eye and kidney disease was discontinued (Institute for Clinical Systems Improvement, 2010). 
On a state level, the Minnesota legislature adopted Minnesota Statute 62U.02 in 2009. 
The statue required the Minnesota Department of Health to establish a standardized set of quality 
measures for health care providers across the state for the purpose of producing an annual report 
on health care quality (Minnesota Department of Health, 2011). The Minnesota Department of 
Health contracted with Minnesota Community Measurement, a private corporation of health care 
professionals, in collaboration with Minnesota Hospital Association, the Minnesota Medical 
Association, the University of Minnesota, Stratis Health (the Medicare Quality Improvement 
Organization  for Minnesota), and many other community collaborators and health care 
organizations to design, collect, and report new measures for diabetes care , vascular care, and 
the patient experience of care (Minnesota Department of Health, 2011).  The Minnesota 
Department of Health adopted the first set of administrative rules (Minnesota Rules, Chapter 




2009. Physician clinics and hospitals were required to submit data needed to calculate applicable 
quality measures and perform risk assessment starting January 1 2010. Minnesota Community 
Measurement collected data submitted directly by physician clinics via a web-based portal 
To meet their statutory requirements to risk adjust quality measures, the Minnesota 
Department of Health developed a risk adjustment strategy in early 2010 for the first set of 
physician clinic quality measures included in the Statewide Quality Reporting and Measurement 
System. The University of Minnesota and Minnesota Community Measurement’s Measurement 
and Reporting Committee reviewed the methodology in mid-2010. In developing the risk 
adjustment strategy, the Minnesota Department of Health set out to collect data and report 
quality measure results that were comparable across providers while minimizing the data 
collection burden on providers. More comprehensive risk adjustment would have required 
additional data elements be submitted by physician clinics. The more comprehensive adjustment 
was considered too costly and cumbersome. The Minnesota Department of Health, the 
University of Minnesota, and Minnesota Community Measurement continue to research and 
investigate more robust risk adjustment options (Minnesota Department of Health, 2011). The 
measures in the 2011 Health Care Quality Report for Minnesota were recommended and revised 
over the years by Minnesota Community Measurement’s Measurement and Reporting 
Committee, approved by their Board of Directors, and reflect current evidence-based guidelines 
(MN Community Measurement, 2012).  
Numerator components for optimal diabetes care measure specifications for 2012 are the 
percentage of diabetes patients age 18-75 in the measurement period who meet the following 





 HgbA1c less than eight percent 
 Low density lipoprotein (LDL) cholesterol less than one hundred mg/dl 
 Blood pressure at or below 139/89 
 Tobacco nonuse 
 Daily aspirin use for those with documented ischemic vascular disease 
These measures were agreed upon by all organizations participating in the Statewide 
Quality Reporting and Measurement System, are referenced in the systems change organization’s 
Diabetes Report, and are used to assess outcomes for each measurement parameter, and for the 
percentage of patients achieving optimal outcomes in all parameters for the systems change 
project. 
Translating Research into Practice 
Evidence based guidelines are not self-implementing (Green & Seifert, 2005). Changing 
providers long-held patterns of behavior and the environments in which they work is complex 
and difficult (de Belvis, Pelone, Biasco, Ricciardi, & Volpe, 2009; Willens, Cripps, Wilson, 
Wolff, & Rothman, 2011).  Unless barriers to change can be overcome and action taken to 
improve compliance, efforts to develop evidence based guidelines are wasted. 
A review of health care and social science literature reveals numerous studies that 
document the limited success of traditional continuing medical education activities (Dancer & 
Courtney, 2011; Kirkman, Williams, Caffrey, & Marrero, 2001). Case-based learning that aims 
to incorporate evidence based guidelines to change clinical practice and improve disease 
outcomes also produces limited long term change (Mold, Aspy, & Nagykaldi, 2008; Oxman, 
Thomson, Davis, and Haynes, 1995). Learning alone, especially as a single event, is not 




Hogg, and Baskerville, 2001; Pike, Indge, Leverton, Ford, and Gilbert, 2010; Sperl-Hillen et al., 
2010; Stolee et al., 2009). Audit and feedback systems for clinical management show only small 
to moderate gains in successful chronic disease management (Jamtvedt, Young, Kristoffersen, 
O'Brien, & Oxman, 2010). Brown et al. (2011) found that an integrated, web-enabled initiative 
offered performance improvement and continued medical education as a unified entity for 
diabetes management.  However, most authors have documented particularly poor outcomes in 
attempts to alter practice behaviors in diabetes and other chronic diseases. In studies where initial 
practice changes to improve disease outcomes did occur, these changes were not sustained and 
improved outcome measures did not continue (de Belvis et al., 2009; Kirkman et al., 2001; 
Lemelin et al., 2001). Generalized guidelines for continuous quality improvement were also not 
successful (Kottke & Solberg, 2001).  Main, Curtis, Pitts, and Irish (2009) did have some success 
with improvement in ongoing medical education through peer appraisal of learning, but did not 
relate this to a change in practice behavior or clinical outcomes. 
A systems approach with multifaceted learning was found to produce the greatest success 
in changing provider behavior to incorporate evidence based practice and sustaining that change 
(Renders et al., 2001). In addition, chronic disease markers tended to improve both for 
intermediate and outcome measures (Damberg et al., 2010; de Belvis et al., 2009).  
Organizational interventions with structured, regular review of patient outcomes had a positive 
effect on processes of care (Renders et al., 2001). The most effective feedback was outcome 
focused and occurred in real time (Doran & Sidani, 2007).  
Change in Organizations 
Factors that produced the sustained changes in clinical practice and resulted in improved 




(Pike et al., 2010; Renders et al., 2001; Sperl-Hillen et al., 2010). Such cultures exhibited strong 
leadership to champion and support change, created an environment that supported individuals 
through the change process, developed opportunities for teamwork and interaction, addressed 
participants attitudes about the change, and tailored the change to each site (Fox, Swanson, 
Kahn, Glaser & Murray; 2008, Ilag et al., 2003; Mathers, Maso, Heyrman & Gaspar, 2007; 
Ploeg, Davies, Edwards, Gifford, and Miller, 2007; Solberg, Klevan & Asche, 2007). 
Interventions that utilized a multicomponent strategy, with a variety of methods that introduced 
process changes, and incorporated clinical practice guidelines were more successful (Benjamin, 
Schneider & Hinchey, 1999; Dancer & Courtney, 2011, Mold et al., 2008; Oxman et al., 1995). 
Damberg et al. (2010) found a positive correlation between large practice organizations size and 
performance on technical quality and patient experience. Fish, Munro, and Bairstow (2009) 
found that change occurred more readily when individuals were not completely free to choose 
their part in the change process and when standards of performance were connected to features 
of people’s tasks, tools, and operating environments. In addition to system components, Sperl-
Hillen et al. (2010) found that improvement in diabetes measures was tied to early drug 
intensification, an increase in continuity of care, participation in diabetes quality initiatives, and 
the use of multidisciplinary resources. 
Practice Facilitation 
Much of the literature on the incorporation of evidence based guidelines into clinical 
practice refer to the use of facilitation and practice facilitators as an important feature of a 
multicomponent intervention. Clinically based personnel, most often nurses, were seen as 
essential players in the implementation and perpetuation of practice changes. When supported by 




2012; Doran & Sidani, 2007; Jaen et al., 2009; Kottke & Solberg, 2001; Lemelin et al., 2001, 
Margolis et al., 2004; McAllister & Osborne, 2006; Mold et al., 2008; Pike et al., 2010; Renders 
et al., 2001). Physicians alone were found to implement guidelines only one third of the time, 
despite computerized reminders (Willens et al., 2011). In one study looking at diabetes processes 
in clinical practice, the only practices that continued, foot care and blood pressure measures, 
were those done by nurses (Friling et al., 2002; Kirkman et al., 2001).  
A model proposed by Kitson, Harvey, and McCormack (1998) utilized a system of 
practice facilitation to assist providers to implement new guidelines into daily practice. She 
defined facilitation as a technique by which one person “makes things easier” for others (Kitson 
et al., 1998). Building on Kitson’s conceptual framework, Stetler et al. (2006) further expanded 
the definition to include a deliberate and valued process of interactive problem solving and 
support that occurs in the context of a recognized need for improvement, and a supportive 
interpersonal relationship.  
The practice facilitator role has been utilized in Europe since the early 1980s (Telligen, 
2012), but is a relatively new concept in the American health system.  In the U.S., the role 
evolved from the Department of Agriculture’s use of agriculture experts who visited farms to 
assist the farmers’ to incorporate best practices into their daily work (Grumbach, Bainbridge, & 
Bodenheimer, 2012). In 2003, Donald Berwick, proposed the model for use with physicians in 
rural practices (Nagykaldi, Mold, Robinson, Niebauer, & Ford, 2006). In 2009, Kevin Grumbach 
and James Mold, proposed a similar model be used to promote best practices in health care. By 
2010, the Affordable Care Act authorized the formation of the Primary Care Extension Program 
to develop models of practice coaching. Since then several large state-based studies conducted in 




model to be a cost effective means of improving patient care through enhanced systems and 
adherence to best practices in primary care practices  (Agency for Healthcare Research and  
Quality, 2008, Bodenheimer, Wagner, & Grumbach, 2002).  It was determined that the total 
estimated savings from practice facilitation equaled approximately $2.8 million for the 
Oklahoma Sonner Care Program (Telligen, 2012).    
The most recent Institute of Medicine report supports the role of practice facilitator as an 
example of the expanding role for nursing (Institute of Medicine of the National Academies, 
2010).  Dogherty, Harrison, & Graham (2010) found that facilitation is now being viewed as a 
distinct role as well as a process. Basic activities of the role are to provide project management 
and leadership, tailor activities to the local context, and link disease outcomes to medical and 
nursing processes. (Dogherty et al, 2010).  Sipila, Ketola, Tala, and Kumpusalo (2008) found 
that facilitators did a better job of promoting multiprofessional teamwork.  Stetler et al. (2006) 
emphasized that facilitation is a deliberate process of interactive problem solving and support in 
the context of a recognized need for improvement and supportive interpersonal relationships. 
Nagykaldi et al. (2006) also found that facilitators were in a unique position to build 
relationships, improve communication, and share resources within the practice seeking to 
improve care.  
The literature shows that the facilitator role is a distinct one with crucial behaviors and 
activities. It is gratifying and affirming to read articles by several authors who propose that 
nursing, especially advanced practice nursing, is in a unique and ideal position to serve as 
practice facilitators (Doran & Sidani, 2007; Kirkman et al., 2001; Renders et al., 2001; Sipila et 






A review of the literature substantiates the need to improve the quality of care for persons 
with diabetes and to work more closely with care providers to change the health care system to 
better employ principles of comprehensive chronic disease management. Both providers and 
recipients of care should remain the focus of positive change processes that incorporate 
evidence-based guidelines to guide practice.  
Practice facilitators appear to have a positive impact on implementing change within 
practices, empowering providers to improve care delivery, and incorporating multiple systems 
and disciples to sustain necessary change. The role of practice facilitation needs further research 
as it has the potential of being a cost effective means to improve the quality of care across 
disciplines while offering much needed support to overworked clinicians. Advanced practice 
nurses are ideally poised and should be encouraged to equip themselves to move into such 
positions of leadership. They can serve as facilitators to advocate for a positive change, improve 
health care quality, and serve as a bridge to unite various disciplines and sectors in health 
promotion activities for chronic disease.  
There is clearly a need to continually review the components of evidence-based 
guidelines as implemented in disease outcome measures, and question the choices made for 
ongoing surveillance. Outcome measures should document monitoring and treatment for all the 










The purpose of the project was to assist primary care providers through the use of a 
practice facilitation model to improve the quality of diabetes care within their primary care 
clinic. The specific aims include monitoring of the diabetes patient registry for outcome markers 
to (a) improve HgbA1c to less than eight percent; (b) decrease low density lipoprotein 
cholesterol to less than 100 mg/dl; (c) maintain blood pressure at or below 139/89; (d) decrease 
tobacco nonuse; and (e) add daily aspirin for those with documented ischemic vascular disease. 
This project used longitudinal, prospective, mixed methodology where quantitative 
repeated measures were triangulated with qualitative data to provide a comprehensive 
understanding of the diabetes outcomes. 
Setting 
This project took place in a small primary care clinic located in a suburban setting. The 
clinic recently merged with a larger organization in the Midwest, United States. The larger 
organization had a system in place for improving diabetes outcomes and in 2008 and 2011 
received the Minnesota Bridges to Excellence award for superior patient care in diabetes 
(Bridges to Excellence, 2011). The small clinic was given outcome goals to achieve within a 
twelve month period, but little training or leadership in how to achieve the goals. In an attempt to 
further incentivize the quality improvement efforts, the clinic manager was directed to post all 
providers’ diabetes scores in the clinic break room on a monthly basis. 
Sample 
Six physicians and six clinical assistants, forming six provider teams (one physician 




Three physicians were board certified in internal medicine and three physicians were board 
certified in family practice. The number of patients on each physician registry ranged from 
sixteen to one hundred six with a total of three hundred sixty-six patients on all the diabetes 
registries reviewed.  
Ethical Considerations 
Project participation was voluntary and participants were chosen on a first come first included 
basis. Providers were informed verbally and in writing using informed consent about the purpose 
and structure of the project. IRB approval was obtained from the organization and St Catherine 
University. The study was initiated once participants agreed to participation for the entire four 
month period. Confidentially was maintained throughout the project. No identifiable patient data 
were used in the project and access to patient records was under strict Health Insurance 
Portability and Accountability Act (HIPAA) guidelines. All meetings with providers and 
provider teams were held in private, secure locations in the clinic. The content of each meeting 
was not shared outside of the session and all recommendations developed as part of the project 
were given exclusively to the provider teams. Participants were assured that no part of the project 
interactions would be transmitted to clinic or health organization administration. It was 
recognized that participants might feel uncomfortable about communicating their needs for better 
diabetes patient management outcomes. However, this burden was no more than encountered 
daily in routine clinic activities and surveillance. 
Project data were stored in a locked cabinet in the facilitator’s office and was limited to 
the facilitator, data analyst, and academic advisor. All data will be destroyed at the completion of 






Outcome measures used in the project were based on the Minnesota Community Measures and 
accepted for use across the health care organization. Measures were: 
• HgbA1c less than 8% 
• Low density lipoprotein (LDL) cholesterol less than 100 mg/dl 
• Blood pressure at or below 139/89 
• Tobacco nonuse 
• Daily aspirin use for those with documented ischemic vascular disease 
A composite measure of all five outcome measure was recorded in the diabetes registry on a  
monthly basis for each provider. Calculation of the monthly composite measure was based on 
Minnesota Community Measures guidelines, and accepted for use across the health care 
organization. 
Protocol 
Six physicians in the adult medicine clinic of a primary care clinic in suburban Minnesota 
were invited to participate in the project. The diabetes registry for each provider was used as the 
basis for all interactions, and was initially reviewed to determine individual provider practice 
patterns for diabetes management. Specific recommendations to improve diabetes outcome 
scores that were not at target were developed by the practice facilitator who is a nurse 
practitioner and diabetes specialist. Three interactive sessions were scheduled between the 
practice facilitator and each provider or provider team. Providers were encouraged to include 
their clinical assistants (physician-assistant provider teams) in the meetings as research has found 
that auxiliary clinical personnel are important to successfully implementing and sustaining 




minutes, and the final session was via electronic mail, and scheduled for fifteen minutes. 
Sessions occurred during regular clinic hours and time was blocked in each provider’s schedule 
to allow for uninterrupted communication. Evidence-based, organizationally approved practice 
guidelines for diabetes management were used to structure recommendations for care. Care goals 
and specific interventions for improvement of each suboptimal outcome score were discussed 
and recorded for future reference. System processes for ongoing disease management and patient 
tracking utilizing the electronic medical record were reviewed with the provider team. At each 
session the diabetes registry report, prescribed diabetes, lipid, and blood pressure medications, 
lab orders, and results, vital signs, and any communication with the patient were reviewed. 
Attention was directed to glycemic, lipid, and blood pressure control, and tobacco cessation as 
appropriate. Aspirin use was reviewed for all diabetes patients with documented vascular 
disease. At every session written recommendations were developed in collaboration with the 
provider team. These recommendations served as a platform for practice changes over the 
ensuing month and incorporated comments and suggestions from the provider team. Copies were 
distributed to each person at the meeting but not shared with general clinic staff or 
administration. Additional phone and electronic support and feedback were available to each 
provider team between each session throughout the project. Follow-up sessions began with a 
review of changes in the diabetes registry and clinical practice since the previous meeting. 
Opportunity to discuss management or practice issues was planned for every session. The 
practice facilitator and provider teams were employed by the health care system and covered by 
HIPAA guidelines to access electronic medical records for patients on the diabetes registry. No 
patient data were used for completion of the systems change project. Diabetes registry outcome 




Scores for four months before the project, four months during the project, and one month 
following the project were used to establish a baseline for outcome measures and document 
changes as a result of the intervention. Analysis of quantitative data from changes in outcome 
scores was conducted at the conclusion of the project. Qualitative analysis of provider responses 
to an open-ended question administered at the end of the project was also included. 
Data Collection 
 The healthcare system diabetes outcomes registry was utilized throughout the systems 
change project to track changes in percent outcome measures before, during, and for one month 
after the project. The registry also served as a tool to target specific areas of diabetes 
management that required provider team intervention. Data sets for the registry were established 
and verified through Minnesota Community Measures, and were the same data sets utilized by 
all the healthcare organizations in Minnesota currently participating in the state wide diabetes 
quality improvement efforts. One stated advantage for using the established data sets for all 
organizations was the ability to compare quality of diabetes care across all participating 
healthcare organizations in the state. The Minnesota Department of Health promoted this 
uniformity 
Data Analysis Plan 
Outcome measures for each provider from point zero to one month following the 
intervention were included in the data analysis. Inclusion of data from the fifth month permitted 
results from the third and final interaction to be assessed. The degree of change and number of 
patients achieving optimal outcomes for each provider were determined using descriptive and 
inferential statistics. Since the data were repetitious in nature, repeated analysis was performed to 




assess whether the target 38% in outcome measurement was accomplished, and to what degree 
improvement was achieved. 
Both fixed-effects models and random-effects models were used to analyze the data. A 
fixed-effects model assumes that the data being analyzed have the same quantitative effect and 
that the differences observed are residual error. In the project, the five outcome measures (LDL-
cholesterol, blood pressure, HgbA1c, tobacco nonuse and aspirin use) and the composite 
measure were considered fixed effects. However, each of the six providers responded differently 
during the course of the project. The spread in the data were caused not only by the residual error 
but also by between-provider differences. This type of situation required a random-effects model. 
A random-effects model enabled the assessment of an entire sample of data for subgroup 
differences without needing to split the data into subgroups and take into account the inherent 
differences of individual providers and practice styles (Cleophas & Zwinderman, 2008; Riley, 
Higgins, & Deeks, 2011).  
Qualitative analysis of the open-ended question was done to look for theses related to the 
second and third aims of the facilitation process. Individual provider response to the process was 














 The purpose of the project was to assist primary care providers to improve diabetes 
quality of care within their primary care clinic. Project aims were to (a) improve diabetes 
outcome measures to a target of 38% by the completion of the project; (b) increase providers’ 
knowledge and confidence in caring for their patients with diabetes; and (c) improve provider 
team processes for the delivery of evidenced-based care to their patients with diabetes by more 
consistent use of the diabetes registry data to individualize treatment plans. 
Six providers from the medical clinic participated in the project. Data were derived from 
the organizational diabetes registry for each provider. Diabetes outcome measures (percent LDL, 
blood pressure, A1C, tobacco nonusage, aspirin use) and the monthly diabetes composite 
measure of all five outcomes measures were averaged for each participant for four months prior 
to the start of the project. The resulting average was used as a baseline. Diabetes outcomes 
measures and composite measures were tracked for each of four months during the project. 
Diabetes outcome measures and the composite measures were tracked for one month following 
the project to capture improvements made during the last month of the project. Correlation 
analyses and mixed model regression analyses were used to examine the data.  
Aim 1: Improve diabetes composite scores to 38% by the end of the project. 
Percent composite measures were reviewed at month five, and showed that two of six 
participants achieved the goal of 38%. One participant achieved 38.0%, and a second achieved 








Change in Composite Measures for Providers Before and After the Project 
 
 
1.) Multi-level Modeling 
      Each element of the composite measures was further examined using multi-level- 
modeling. The reason for multi-level-modeling originated from the practice environment. Since 
variation in care is, in part, related to individual providers, it is important to account for these 
variations when changes in diabetes outcome measures are evaluated. All model fitting was done 
using linear mixed-effects analysis. There was a positive change in each measure as the project 
progressed.  
a) Low density lipoprotein (LDL): The individual impact of this project can be seen in 
the LDL measure. The goal for people with diabetes is to have an LDL outcome measure that is 
less than 100 mg/dl. Table 1 clearly shows that patients’ LDL levels were decreased to a 

















clinician’s management of diabetes (-0.397).  A decrease in the LDL-cholesterol level is 
anticipated to improve diabetes patient outcomes. 
Table 1 
Effects of Clinicians (random effects) on LDL (fixed effects) 
Random Effects    
Group Name Variance  Std Dev Correlation 
Intercept 4.176578   
Monthly    -0.397 
Residual  3.168111  
 
Fixed Effects     
Group Name Value Std Error t-value p-value 
Intercept 50.92778 1.945132 26.18217 0.000 
Month 0.84333 0.309176 2.72768 0.017 
   
b) Blood pressure (BP): Another diabetes outcome measure is the patients’ blood 
pressure which is recorded at every visit to ensure that blood pressure is within a normal 
range. The goal for blood pressure is at or below 139/89. The results indicate that the 
intervention was not effective as the fixed effect (p=0.6085) was not significant (see Table 
2). Blood pressure is affected by many factors such as blood pressure cuff size, the patient’s 
position at the time of measurement, the length of time the patient was permitted to be in 
a resting position prior to measurement, the mental state of the patient at the time of the 
clinic visit, the skill of the person doing the measurement, etc. It is possible that other 
contributing factors explain why the blood pressure was not improved significantly. 







Effects of Clinicians (random effects) on Blood Pressure (fixed effects) 
Random Effects    
Group Name Variance  Std Dev Correlation 
Intercept 5.132988   
Monthly    -0.426 
Residual  4.27367  
 
Fixed Effects     
Group Name Value Std Error t-value p-value 
Intercept 83.06706 2.4465811 33.95230 0.0000 
Month 0.21595 0.4170674 0.51779 0.6085 
 
c) Glycosylated hemoglobin (Hgb A1c): Diabetes patients’ A1c were checked every 90 
days to ensure that blood glucose was within a therapeutic range. The target for HgbA1c was less 
than 8%. As illustrated in Table 3, the results indicate that the intervention was effective as the 
fixed effect of the HgbA1c was significant (p=0.004). The random effect (clinicians’ effect) is 
explained by the correlation of -0.344. This result means that the individual clinicians’ effects 
were moderately correlated in decreasing the HgbA1c level.  The negative sign is encouraging 
and indicates that blood glucose levels were decreasing while patient outcomes were improving. 
Table 3 
Effects of Clinicians (random effects) on HgbA1c (fixed effect) 
Random Effects    
Group Name Variance  Std Dev Correlation 
Intercept 4.45655   
Monthly A1c   -0.344 




Fixed Effects     
Group Name Value Std Error t-value p-value 
Intercept 75.50913 2.0018339 37.71998 0.000 
Month 0.86357 0.2757865 3.13130 0.004 
 
d) Tobacco Nonusage: The nicotine in tobacco is known to constrict blood vessels 
through the body and contributes to further cardiovascular problems including high blood 
pressure, heart attack, high cholesterol, and peripheral vascular disease (claudication). Smoking 
also causes insulin resistance in both diabetic and nondiabetic people which further worsens 
diabetes control, and contributes to the kidney disease, eye disease, and nerve disease seen in 
diabetes. Smoking cessation is seen as essential to optimal health with diabetes. The results of 
the study are very encouraging where the fixed effect of tobacco nonusage is significant 
(p=0.0051); however, a low correlation exists (-0.139) for clinicans’ efforts that does not explain 
this significant outcome (see Table 4). It is possible that knowledgeable clinicians were able to 
energize their patients to change smoking behaviors. 
Table 4 
Effects of Clinicians (random effects) on Tobacco Nonusage (fixed effects) 
Random Effects    
Group Name Variance  Std Dev Correlation 
Intercept 5.52423   
Monthly    -0.139 
Residual  1.301606  
 
Fixed Effects     
Group Name Value Std Error t-value p-value 
Intercept 82.44742 2.2878133 36.03765 0.0000 




e) Aspirin (ASA) Use: The fifth outcome measure that is part of the composite score is the use 
of aspirin. Emerging evidence supports the continuation of daily aspirin use (unless 
contraindicated) for diabetes patients with known ischemic vascular disease and no longer 
supports its use in diabetic patients ages 41 and older who have not yet developed ischemic 
vascular disease. Ischemic vascular disease includes documented heart attack, stroke, and 
atherosclerosis in any part of the body or blood clots in any arteries. Aspirin has been shown to 
reduce the occurrence of further events in such individuals. The results (see Table 5) indicate that 
a change in practice trended toward an improvement in aspirin use but was not significant 
(p=0.2903). In addition, clinicians had a low correlation with this outcome (0.175). The 
nonsignificant results may have been due to a lower number of patients with documented 
ischemic vascular disease or the fact that some clinicians changed their practice to reflect the 
current change in Minnesota Community Measures practice guidelines. 
Table 5 
Effects of Clinicians (random effects) on Aspirin Use (fixed effects) 
Random Effects    
Group Name Variance  Std Dev Correlation 
Intercept 7.569179   
Monthly    -0.175 
Residual  2.268428  
 
Fixed Effects     
Group Name Value Std Error t-value p-value 
Intercept 95.96210 3.1619579 30.348950 0.0000 






2) Overall Fixed Effects 
When examining all five outcome measures without partitioning for random (clinician) 
effect the only significant improvement noted was in glycosylated hemoglobin (HgbA1c). 
Improvement in LDL cholesterol levels trended toward significant (see Table 6). This table 
clearly outlines the importance of using multilevel modeling as random (clinician) effects are 
submerged in the error term, making the results nonsignificant. The above noted tables provide 
clarity into the role of clinicians on the diabetes outcome measures, and how they are correlated 
with each individual marker. 
Table 6 
Paired Samples for Diabetes Outcome Measures 
































3)  Overall Clinician (random effects) on all outcomes 
There was a significant improvement in percent total composite outcome measures for all 
outcomes (see Table 7) from the beginning to the end of the project (p= 0.01). In addition, this 
correlation is moderately strong (-0.491) and has contributed to improving patient outcomes. 







Effects of Clinicians (random effects) on composite outcome measures 
Random Effects    
Group Name Variance Std Dev Correlation 
Intercept 3.938193   
Monthly   -0.491 
Residual  4.019775  
 
Fixed Effects     
 Value Std Error t-value p-value 
Intercept 30.016667 1.9988907 15.016663 0.0000 
Month 1.076667 0.3922898 2.744569 0.0103 
 
Figure 2  
Change in % Composite Outcome Measures 
 
 




Aim 2: Increase in Providers’ Knowledge and Confidence 
An open-ended question was administered to participants at the end of the project. 
Responses were analyzed for themes. Four of the six providers found the experience to be 
positive in terms of increasing their knowledge of diabetes management, improving diabetes 
outcome scores, and increasing their skill in utilizing the diabetes registry. One provider felt the 
project made little change in her care for patients with diabetes, but provided an opportunity to 
review current clinical practice guidelines. This response was labeled as neutral. Another 
provider did not feel the project was of any benefit to his practice and contributed no new 
information about diabetes or the use of the diabetes registry. This response was labeled as 
negative. Outcome and composite measures for all participating providers were compared 
according to whether their responses were positive (blue line) or neutral/negative (red line).There 
was a significant correlation between positive responses and improvement in percent composite 
outcome measure (p= 0.0075) despite the fact that the providers with neutral/negative responses 
started out higher than those providers with positive responses. 
Figure 3 
Clinician’s Attitudes and Composite Outcome Measures 
 Note. % Composite Measure, (p=.0075) red=negative attitudes, 




There was also a significant correlation between positive responses, and improvement in 
percent LDL less than 100 mg/dl (p= 0.002) despite the fact that the providers with neutral or 
negative responses started out higher in this variable as well. 
Figure 4 
Relationship between Attitude and LDL Outcome Measure  
 
Note. % LDL >100 mg/dl, (p=.002) red=negative attitudes, blue=positive attitudes 
Aim 3: Improve Health Team Processes  
The final aim was to improve health team processes for the delivery of evidenced-based 
care to their patients with diabetes by more consistent use of diabetes registry data. 
Data from responses to the open-ended question were subjected to thematic content 
analysis. Content was divided into four categories, changes in diabetes knowledge, use of the 
organization’s diabetes systems, working with patients, and improved provider team relations. 
Responses were coded for each category from which overarching themes were then identified.  
Improvement in knowledge of diabetes and diabetes management. Five of six 
providers noted some improvement in their knowledge of diabetes or diabetes related 




medications and one mentioned that the discussion of when to initiate insulin therapy was 
helpful. Three providers found the incorporation of protocols for diabetes and cholesterol 
management useful. Participants commented, “It was a help to work with you, especially to go 
over the diabetes medication and when to start insulin,” and “I found the clinic protocols were 
useful.” 
 Increased ability to work with the organization’s diabetes systems. The same five 
providers expressed increased understanding of the various aspects of the diabetes management 
systems currently in use by the organization. Four of the five specifically referenced improved 
use of the diabetes registry and one mentioned increased use of the diabetes education support 
systems. Participants reported, “I find it easier to track my diabetes patients and to use the 
diabetes workbench on a regular basis,” and “I did not know about the diabetes education 
program.  I am sending some of my patients now.” 
 Working with their diabetes patients. Four of six providers felt the project improved 
their ability to work with patients and/or improve outcome measures for their patients. They 
expressed increased comfort with the visit process and more efficient use of their time which 
produced a more relaxed encounter. Comments included, “I think my patients did benefit from 
what I learned and my numbers got better,” and “[it was good to have]… time available to 
discuss the more difficult patients with someone who knew more about diabetes.” 
 One provider felt the project was of no benefit to him and did not change the way he 
practiced diabetes management. He felt he was already delivering good care and that some of his 
patients were particularly hard to treat. “I take good care of my patients, but I cannot make them 





 Improved provider team processes. Four of the six providers felt the project improved 
how they worked with their clinical assistants to care for their diabetes patients. Most felt there 
was clarification of respective tasks and that the process of reviewing the reports each month was 
becoming easier. Changes in treatment and follow-up of patients were improved. A participant 
reported, “My nurse was able to help me more… I think we can work better to keep up every 
month.” Some participants indicated, “It was a good opportunity to talk with my CNA so we 
could develop a plan for how to better follow the patients,” and “My CNA was able to order lab 





















 Diabetes is one of the most serious public health problems of the twenty-first century 
(Albright, 2007; Glasgow et al., 1999; Meetoo, 2008). The rate of increase in the occurrence of 
diabetes, and its complications has placed a tremendous burden on the American health care 
system, and threatens to affect close to one third of the population in the next 30 years.  Diabetes 
complications markedly reduce the quality and length of life, and contribute to enormous health 
care costs. Several large studies have shown that effective treatments and practices may 
substantially reduce the impact of diabetes (Herman, 2007, ). 
 There has been significant progress in the last 15 years in the development of quality 
measures for diabetes care. Most of diabetes care occurs at the primary care level (Willens et al., 
2011). This project was developed to pilot a facilitator model for system change using evidence 
based quality measures to improve diabetes outcomes in a small primary care clinic. The project 
aims were to a) improve diabetes outcome measures to a composite measure target of 38%; b) 
increase providers’ knowledge and confidence in caring for their patients with diabetes; and c) 
improve health team processes for the delivery of evidence based care and more consistent use of 
registry data. Results indicated significant improvement in three of five diabetes outcome 
measures, and a significant improvement in composite measures for diabetes management. 
Quality Measures and Diabetes Care 
 Performance measures for diabetes have been in place since the late 1990s. There is  
evidence that control of outcome measures such as LDL-cholesterol, blood pressure and HgbA1c 
has a positive impact on reducing the severity and progression of diabetes complications. Trend 




for lower limb amputations, and the incidence of diabetes related end-stage renal disease 
(Centers for Disease Control and Prevention, 2012).  There is increasing evidence that 
improvements in these quality measures translates into significant health care cost savings over 
several years (Agency for Healthcare Research and Quality, 2008). The number of patients 
covered by health plan and state surveillance systems for diabetes quality care has also increased 
across a range of settings (Centers for Disease Control and Prevention, 2012). Improvement in 
process measures for diabetes (eye exams, dental exams, foot exams, diabetes education 
referrals, etc.) have been easier to maintain than improvement in outcome measures (Jamtvedt et 
al., 2010; Landon et al., 2007). Unfortunately, improvements in process measures do not relate to 
improvements in outcome measures (Mangione et al., 2006; Selby et al., 2007). Outcome 
measures are directly associated with risk factors. Adequate control of risk factors is strongly 
associated with improved clinical outcomes for cardiovascular disease, microvascular 
complications, and mortality (Albright, 2010). 
 Pay for performance initiatives have been used in multiple systems in an attempt to 
sustain positive quality changes. The effect of such initiatives remains controversial (Coleman & 
Hamblin, 2007; O'Connor, 2012). Several studies show that improvements decreased after 
incentives and feedback were removed, despite computer generated feedback support (O'Connor, 
2012; Stolee et al., 2009). Incorporating a variety of quality improvement methods have 
produced the greatest improvement in outcomes, but do not necessarily guarantee that such 
improvements will continue over time. 
 From a provider perspective, the pay for performance system places a great deal of stress 
on the care delivery end of the process. Diabetes care occurs predominately in the primary care 




reimbursement and an shortened time-frame in which to meet with patients. There is insufficient 
time allocated to help care providers understand the elements of quality improvement changes 
that will impact their daily practice. Tying reimbursement to production can disproportionately 
penalize those physicians who are working with underserved populations, low income groups or 
those patients with a high level of socioeconomic disadvantage. Weak leadership can also 
negatively impact how well providers do by not providing the support necessary to successfully 
manage the many elements of chronic disease care or maintaining an environment where quality 
of care is stressed.  
 In response to this added pressure, some providers have become adept at stacking their 
patient panels in a favorable direction by limiting access to those who are less ill and those with 
easier to manage chronic and acute illnesses. The variable income associated with pay for 
production has resulted in many care providers moving from primary outpatient clinics to the 
more predictable, salaried positions in specialty services or inpatient settings. 
 Improving the quality of care in diabetes and other chronic diseases is an important and 
essential task. The impact of system changes on those providing care must be taken into account 
and support systems developed and maintained to assist them on a daily basis. The facilitator 
model offers just such a support, not only to improve quality of care, but also to sustain the 
quality and provide much needed support to an overworked segment of the health care delivery 
system. 
Issues with Quality Measures 
 The use of dichotomized quality measures is easy to understand and report, but selection 
of such measurement thresholds is challenging, subject to change, and does not allow for 




improvements in measurement outcomes that have not been sufficient to achieve targeted levels, 
but still have a potentially significant impact on disease outcomes. There is also the implication 
that all patients above measurement targets need more aggressive management or additional 
pharmacotherapy which increases the risk of overtreatment. The benefits of increased treatment 
further diminish as patients approach the target measurement level while the risks of treatment 
related side effects and the cost of treatment increases. 
 The exclusive use of outcome measures as a means of measuring quality of care does not 
take into account the complexity of chronic disease management. Diabetes management covers 
many behavioral, organizational, and clinical determinants that are not accounted for by 
assessing outcome or composite measurements. There should be greater importance assigned to 
defining and measuring the relationship between care givers and patients. The partnership 
between patients, families, communities, and health care teams is a crucial component of care 
management and the development of successful plans of care. This aspect of care is difficult to 
assess and even harder to measure, but is an essential component of quality care. 
 Composite diabetes quality measures have been used as a means of improving the 
reliability of performance measurement and ranking quality within and between health care 
systems. Current composite scores tend to weigh each outcome measure equally which does not 
take into account the clinical significance of individual measures. Because such scores reduce a 
set of measures to a single dichotomous score for each patient there is a great deal of information 
that is missing. This results in a lack of sensitivity for distinguishing between plans or physicians 






Patient Reports and Quality Measures 
 Self-management education is an essential aspect of diabetes care and requires active 
engagement on the part of patients and health care provider teams.  Current quality measurement 
systems do not include the collection of patient reported information. Such information has a 
direct impact on the patient’s understanding of disease processes and treatments, adherence to 
treatment plans, and disease outcomes. Patient reported information is essential to understanding 
patient preferences, and goals, decision making practices, self-care behaviors, psychosocial 
functioning, and risk factors, and patient-health system relations (Fox & Chesla, 2008). There is 
a need to develop a standardized set of behavioral and psychosocial patient-reported measures 
that can be incorporated into the electronic medical record and utilized as part of a more 
comprehensive quality performance measurement system. 
 There is great need for a tool that will elicit information related to how patients perceive 
their health and what their personal health goals may be. Providers need an opportunity to see 
how the treatment plan is being incorporated into patients’ lives and what obstacles patients 
encounter as they work to achieve personal health goals. Especially in chronic disease, there is 
often a mismatch between patient expectations and those of health providers. This mismatch is 
never clearly identified and significantly handicaps both parties as they try to interact. Behavioral 
health has developed a simple, numbered scale to determine levels of depression. This tool is 
clear, and easy enough for patients to complete in three minutes during a clinic encounter. Scores 
from this scale are part of ongoing medical records and are currently used to measure response to 
treatment. A similar tool to measure response to chronic disease management would be an 
excellent way for patients and providers alike to determine progress toward individual health 




this essential information. The current study did not assess patient self-reports. These data could 
potentially differentiate between the effect of providers’ actions and the impact of patients’ 
responses, and offer concrete ways to further effect positive change. 
Advanced Practice Nursing and Quality Measures 
 Nursing at all levels plays a pivotal role in transforming the health care system and 
improving the quality of care. The Institute of Medicine report on the Future of Nursing (2010) 
strongly supports both the expansion of the advanced practice nursing role and the need for 
lifelong learning as an essential component of professional nursing. The role of practice 
facilitator provides an excellent opportunity for advanced practice nursing, especially those at the 
doctorate of nursing practice level, to expand the boundaries of practice, promote positive system 
change, advance the quality of health care, and place both the patient and health care provider 
team at the center of the change process. The multifaceted nature of practice facilitation requires 
a level of knowledge management and brokering that is dependent on a broad perspective and 
extensive experience in the health care system. Systems thinking and population management are 
essential skills that are part of the unique training of the doctor of nursing practice prepared 
advanced practice nurse. The ability to assess care processes, incorporate different sources of 
information and research, evaluate clinical outcomes and perform impact evaluations are 
necessary to achieving ongoing quality improvement. Intervention must be tailored to the unique 
settings of each clinical practice or health care system. The doctor of nursing practice advanced 
practice nurse is well placed as a clinical leader. Such a professional can promote evidence based 






Limitations of the Project 
 The project showed a small, but significant improvement in outcome measures for LDL-
cholesterol, glycosylated hemoglobin, and tobacco nonuse, and a small, but significant 
improvement in the composite measure for diabetes care. These results support findings from 
published studies using similar practice facilitation approaches. Since this was a pilot study these 
results should be interpreted with caution.  The problem related to the small sample size of this 
pilot is a serious challenge and was insufficient to provide statistical power for the project 
question. Variation in delivery of facilitation services was unavoidable as the needs of different 
providers and time constraints of the clinic setting dictated the content of each session. The 
outcome measures and composite measures data used for analysis were accepted as both valid 
and reliable as they derived from the organization’s diabetes registry. The outcomes data could 
not be verified since data on the diabetes registry were obtained from the organization’s audits of 
the electronic medical records and laboratory data and were not directly obtained in a controlled 
setting for use in the project. 
Four of the providers spoke English with a notable accent which potentially influenced 
the level of provider-patient communication. Patient understanding of and response to, plans of 
care are just as important as provider’s actions to improve outcomes. As previously mentioned, 
several studies have identified the need for patient referenced feedback as an important 
component of improving quality of care (de Belvis et al., 2009; O'Connor, 2012). The challenges 
of communication issues between providers and patients could have contributed further to the 
variation in provider practice. 
 The systems change project was a prospective, mixed methods design pilot study. The 




response to a major change in clinical practice.  An assumption at the outset was that any 
improvement in diabetes outcomes would have a greater likelihood of being sustained through 
understanding the response of providers to the change process. Changes in practice that are 
directed from the top down will be more likely to succeed if the change is tailored to the unique 
setting of each clinic and clinician and the subjective response to the change is taken into 
account. To this end, data were collected in a sequential manner with outcome and composite 
measures tracked through the course of the project, analyzed, and then compared to qualitative 
date from analysis of an open ended question at the end of the project. This approach was an 
efficient way to collect data as responses to the open ended question took more time to collect 
and analyze and would have added significantly to the complexity of the project if administered 
concurrently. Adding the question at the end, allowed the clinicians to have more experience 
working with a new system before giving a response. Unfortunately, sequential data collection 
did not permit any adjustment in the facilitation process during the course of the intervention.  
The short duration of the pilot and the lack of input from the clinical assistants further detracted 
from the amount of improvement that could have potentially occurred and the richness of the 
feedback obtained.  
Recommendations 
Practice Impact 
The translation of research into practice through the use of evidence based guidelines is 
an essential, yet complex process. There continues to be gaps that are not adequately addressed 
by more conventional methods of continuing medical education, electronic alerts and reminder 




had a positive impact on the quality of care and lead to a decrease in complications of diabetes. 
Improved outcomes also lead to substantial cost savings.  
The use of practice facilitation to promote quality improvement needs further exploration, 
but appears to offer a creative means of enhancing the quality of patient care and offering 
support to health care team members. A recent meta-analysis showed that primary care practices 
were 2.76 times more likely to adopt evidence based guidelines through practice facilitation 
(Baskerville et al., 2012). Practice facilitation incorporates a hands-on, individualized approach 
that is seen as positive and enabling. Facilitation also brings multiple health team members 
together with a common focus and system support that has the potential for successful and 
sustained change and quality improvement.  
Advanced practice nurses can play a critical role in facilitating evidence based practice. 
Knowledge brokering is a key aspect of the advanced practice role which can be leveraged to 
promote evidence based practice. Practice facilitation is an ideal opportunity for advanced 
practice nurses to utilize the specific knowledge and skills that are unique to their training and 
education. 
Future Recommendations 
Conceptual models for practice facilitation already exist (Dogherty et al., 2010; Fielden, 
Davidson, and Sutherland, 2009; Gallagher-Ford, 2012; Group Health's MacColl Institute for 
Healthcare Innovation et al., 2008).  More large-scale, collaborative practice-based research is 
needed to understand how facilitation can further support the adoption of evidence based 
guidelines, the relationship between context and components of facilitation, sustainability, and 




As noted in Appendix A, the cost of implementing a practice facilitation project is 
relatively low. This project budget was just over $13,000 which included temporary loss of 
productivity for the provider teams’ participation in facilitation meetings. However, the return on 
investment for 4 months of coaching was 260%. The high return came from potential cost 
savings to the health plan from improved diabetes control. Improved control is expected to result 
in fewer short term complications, fewer medical procedures and a decrease in hospitalizations 
and emergency room visits for the one year period. Optimal diabetes control over a ten year 
period for the same number of patients would yield a savings to the health care system of 
$125,154. 
As Appendix B identifies, there are many additional benefits of the practice facilitation 
process that cannot be monetarily quantified. These benefits potentially improve efficiency and 
job satisfaction for providers and customer satisfaction for recipients of care. An increase in the 
retention of skilled health care professionals within a health system and more efficient patient 
care delivery reduces operating costs and by association, health care costs substantially. 
Finally, the use of random effects modeling provided a more sensitive means of 
analyzing the influence of providers on changes in outcome measures. The more traditional form 
of analysis in biomedical research is the fixed effects model. Fixed effects modeling is based on 
averages and the assumption that a single true effect size underlies all study results (Polit & 
Beck, 2008). With fixed effects modeling observed estimates are thought to vary only as a 
function of chance. However, clinical outcomes are influenced by a variety of factors that must 
be accounted for in explaining the results. A random effects model does a better job of allowing 
for the influence of these factors on the outcome and permits the inclusion of potentially 




and the loss of important data.  By controlling out context, fixed effect modeling effectively cuts 
out much of what is going on clinically that should have great importance to the investigator and 
reader alike. Random effect modeling is able to explain and reveal specific differences between 
higher level entities (Bell & Jones, 2012) and is therefore a better choice for clinical research. As 
demonstrated in this project, the influence of providers on outcome measures would have been 
completely missed with just a fixed effects model. This is a lesson to keep in mind for all clinical 
research. 
Conclusion 
Practice facilitation is a creative, cost effective way of improving the quality of patient 
care in diabetes. A practice facilitation model recognizes and supports the essential role of 
multidisciplinary health teams in collaboration with patients to advance health promotion to its 
highest level. Practice facilitators are potentially in an ideal position to not only initiate quality 
changes, but also sustain the improvements that occur. Nurses are in a unique position to 
continue research on practice facilitation as they traditionally have a perspective that 
contextualizes the patient experience and a record of working across disciplines to incorporate 
individualized approaches that maximize health outcomes. Facilitation is a completely different 
vehicle for spreading innovation and improving performance in primary care. There needs to be 
more resources devoted to the training and deployment of practice facilitators. Advanced 
practice nurses should position themselves at the front of this innovation, develop the skills and 
expertise to serve as practice facilitators, and continue the research to develop and evaluate a 
variety of models for practice facilitation. It is imperative to extend the work in practice 
facilitation to incorporate quality care measures in both diabetes and cardiac disease in more 
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Return on Investment 
Project Budget 
Activity  Amount 
Provider time x6 3 hours @ $150.00 x6 $2,700.00 
Facilitator time (3 hours 
meeting + 2 hour prep for ea of 
6 providers) 
24 hours @ $48.00 $1,152.00 
Nursing time x6 3 hours @ $30.00 x6 $540.00 
Lost productivity (includes 
facilitator) 
3 hours @ 150.00 each x6 
3 hours @ $80.00 x6 






Total  $13,257.00 
 
 
Sidorov, et al. (2002) determined that comprehensive care for diabetes in a managed care 
program resulted in per month claims of $394.62 for enrollees in the program versus per month 
claims of $502.48 for those with diabetes not enrolled in the program. Utilizing these numbers 
and adjusting for 2012 using a conversion factor of 1.275 (Oregon State University, 2012)  the 
claims for comprehensive care are $503 per month and the claims for status quo care are $640 or 




outcome measures by the end of the 4 month period. This is a savings of $1,644 per patient per 
year for those with optimal outcomes measures. Using just the 21 patients in the project, the 
annual cost savings is $34,524. Annual return on investment for 4 months of practice facilitation 
is 260%. If optimal control is maintained in just these 21 patients for a period of 10 years, the 
cost savings in 2012 dollars, using a conversion factor of 1.115 (Oregon State University, 2012) 


























Benefits of Participation 
• Improved efficiency in diabetes management activities 
• Increased knowledge in diabetes management 
• Improved diabetes outcome scores 
• Enhanced understanding of health system goals 
• Improved health team interaction 
• Increased job satisfaction/retention 
• More efficient use of diabetes tests, treatments, and surveillance options 
(including increased number of OP visits) 
• Decreased urgent care, emergency and hospital encounters 
• Decreased diabetes complications 
• Enhanced patient satisfaction 
• Increased opportunity for P4P and QI bonuses 
• Streamlined workflow and staff utilization 
 
 
 
 
